GSA Capital Partners’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Buy
+46,793
New +$299K 0.02% 1419
2026
Q1
– Sell
-62,353
Closed -$600K – 2034
2025
Q4
$600K Buy
+62,353
New +$645K 0.05% 691
2025
Q1
– Sell
-29,254
Closed -$202K – 1951
2024
Q4
$202K Sell
29,254
-64,373
-69% -$443K 0.02% 1414
2024
Q3
$690K Sell
93,627
-8,256
-8% -$77.1K 0.05% 700
2024
Q2
$1.07M Buy
101,883
+42,826
+73% +$543K 0.08% 460
2024
Q1
$817K Buy
+59,057
New +$922K 0.06% 580
2023
Q3
– Sell
-20,460
Closed -$679K – 1783
2023
Q2
$679K Buy
+20,460
New +$753K 0.07% 549
2023
Q1
– Sell
-11,949
Closed -$504K – 1796
2022
Q4
$504K Buy
+11,949
New +$460K 0.06% 597
2022
Q3
– Sell
-22,843
Closed -$989K – 1767
2022
Q2
$989K Buy
22,843
+4,394
+24% +$202K 0.15% 151
2022
Q1
$883K Buy
+18,449
New +$914K 0.12% 227
2020
Q4
– Sell
-10,435
Closed -$523K – 1484
2020
Q3
$523K Buy
+10,435
New +$495K 0.09% 360
2020
Q2
– Sell
-13,930
Closed -$304K – 953
2020
Q1
$304K Buy
+13,930
New +$419K 0.08% 478
2019
Q2
– Sell
-5,396
Closed -$258K – 1652
2019
Q1
$258K Sell
5,396
-24,629
-82% -$1.49M 0.03% 1080
2018
Q4
$1.84M Sell
30,025
-16,972
-36% -$1.14M 0.21% 64
2018
Q3
$3.87M Buy
46,997
+1,591
+4% +$126K 0.21% 40
2018
Q2
$3.55M Buy
45,406
+19,142
+73% +$1.48M 0.18% 73
2018
Q1
$1.94M Buy
26,264
+9,648
+58% +$685K 0.1% 302
2017
Q4
$1.13M Buy
16,616
+3,747
+29% +$242K 0.07% 525
2017
Q3
$791K Sell
12,869
-740
-5% -$45.4K 0.05% 670
2017
Q2
$855K Sell
13,609
-54,719
-80% -$3.12M 0.06% 677
2017
Q1
$3.79M Buy
68,328
+2,870
+4% +$148K 0.2% 56
2016
Q4
$3.13M Buy
65,458
+3,760
+6% +$211K 0.19% 71
2016
Q3
$4M Sell
61,698
-10,738
-15% -$604K 0.21% 41
2016
Q2
$3.35M Buy
72,436
+50,774
+234% +$2.05M 0.19% 71
2016
Q1
$829K Sell
21,662
-6,638
-23% -$220K 0.05% 665
2015
Q4
$1.07M Sell
28,300
-21,460
-43% -$791K 0.05% 653
2015
Q3
$2.05M Sell
49,760
-47,334
-49% -$2.03M 0.1% 251
2015
Q2
$4.58M Buy
97,094
+68,664
+242% +$3.72M 0.18% 63
2015
Q1
$1.71M Buy
28,430
+8,195
+40% +$417K 0.07% 444
2014
Q4
$884K Sell
20,235
-9,621
-32% -$425K 0.06% 549
2014
Q3
$1.34M Buy
29,856
+680
+2% +$36.2K 0.07% 343
2014
Q2
$2.16M Buy
29,176
+10,840
+59% +$854K 0.1% 228
2014
Q1
$1.52M Buy
18,336
+14,273
+351% +$1.25M 0.11% 187
2013
Q4
$562K Sell
4,063
-2,151
-35% -$253K 0.04% 763
2013
Q3
$595K Buy
6,214
+778
+14% +$66K 0.05% 659
2013
Q2
$332K Buy
+5,436
New +$302K 0.04% 813

Other funds holding NUS

GSA Capital Partners's NUS Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Nu Skin (NUS) in Q2 2026: 46,793 shares worth $247K. The stake represents 0.02% of the portfolio and ranks #1419 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in NUS as recently as Q4 2025.

GSA Capital Partners first reported a position in NUS in Q2 2013 and has held it in 36 quarters since. The position peaked at $4.58M in Q2 2015. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • GSA Capital Partners held 46,793 shares of Nu Skin worth $247K as of Q2 2026.
  • Nu Skin was a new GSA Capital Partners position in Q2 2026.
  • Nu Skin made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1419 holding.
  • GSA Capital Partners first reported a position in Nu Skin in Q2 2013 and has held it in 36 quarters since.
  • GSA Capital Partners's Nu Skin position peaked at $4.58M in Q2 2015.
  • 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.